Trial reportGeneral thoracic and cardiovascular surgery2022
Computed tomography radiomics-based distinction of invasive adenocarcinoma from minimally invasive adenocarcinoma manifesting as pure ground-glass nodules with bubble-like signs.
Trial report in General thoracic and cardiovascular surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Value of a radiomics model based on high-resolution large matrix target reconstruction images in predicting the invasiveness of lung adenocarcinoma with pure ground-glass nodules.Biomedical engineering online · 2026Article
- Machine learning models based on tumoral, 4 mm-peritumoral, and combined radiomic features for evaluating the invasiveness of lung adenocarcinoma manifesting as ground-glass nodules.World journal of surgical oncology · 2026Article
- Radiomics of Vascular Structures in Pulmonary Ground-glass Nodules: A Predictor of InvasivenessCurrent medical imaging · 2025Article
- Expanding Role of Advanced Image Analysis in CT-detected Indeterminate Pulmonary Nodules and Early Lung Cancer Characterization.Radiology · 2023Review
- Intra- and Peritumoral-Based Radiomics for Preoperatively Assessing the Pathological Subtype of T1-Stage Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodules.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo explore an effective model based on radiomics features extracted from nonenhanced computed tomography (CT) images to distinguish invasive adenocarcinoma (IAC) from minimally invasive adenocarcinoma (MIA) presenting as pure ground-glass nodules (pGGNs) with bubble-like (B-pGGNs) signs. PATIENTS AND
methodsWe retrospectively reviewed 511 nodules (MIA, n = 288; IAC, n = 223) between November 2012 and June 2018 from almost all pGGNs pathologically confirmed MIA or IAC. Eventually, a total of 109 B-pGGNs (MIA, n = 55; IAC, n = 54) from 109 patients fulfilling the criteria were randomly assigned to the training and test cluster at a ratio of 7:3. The gradient boosting decision tree (GBDT) method and logistic regression (LR) analysis were applied to feature selection (radiomics, semantic, and conventional CT features). LR was performed to construct three models (the conventional, radiomics and combined model). The performance of the predictive models was evaluated using the area under the curve (AUC).
resultsThe radiomics model had good AUCs of 0.947 in the training cluster and of 0.945 in the test cluster. The combined model produced an AUC of 0.953 in the training cluster and of 0.945 in the test cluster. The combined model yielded no performance improvement (vs. the radiomics model). The rad_score was the only independent predictor of invasiveness.
conclusionThe radiomics model showed excellent predictive performance in discriminating IAC from MIA presenting as B-pGGNs and may provide a necessary reference for extending clinical practice.
Indexed as
Identifiers
35301662What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.